Wuhan Zhongyuan Huadian Science and Technology Co.,Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Wuhan Zhongyuan Huadian Technology Co., Ltd. (referred to as "Zhongyuan Co., Ltd.") is located in the National Independent Innovation Demonstration Zone - Wuhan Donghu New Technology Development Zone. It is a national high-tech enterprise and one of the first 28 listed companies on the Growth Enterprise Market in China. The company's stock was listed and traded on the Shenzhen Stock Exchange in 2009, with the stock code of 300018.sz. With strong support from all sectors of society and years of unremitting efforts by all employees, the company's business has expanded to the fields of smart grids, healthcare, and industrial investment, with ten wholly-owned and holding subsidiaries; The company has gathered a group of experienced mid to senior professional talents who are interested in engaging in the fields of electricity, healthcare, and industrial investment. It has a product research and development team led by academicians and with a doctoral degree as the core, as well as a sales team that always considers users; The company has established an enterprise technology center, engineering technology research center, and engineering laboratory recognized by Hubei Province, participated in the drafting of more than 40 national, industry, and enterprise standards, and has over 60 invention patents, over 200 software copyrights, and over 100 Class II medical device product registration certificates; The company has established a comprehensive research and development, production, sales, and service system in accordance with standards such as GB/T19001-2016/ISO9001:2015 Quality Management System, GB/T24001-2016/ISO14001:2015 Environmental Management System, and GB/T45001-2020idtISO45001:2018 Occupational Health and Safety Management System. In terms of smart grid business, the company mainly focuses on the research and development, manufacturing, and sales of products required by users in smart substations, smart distribution networks, and new energy applications, and provides related services. The main products include power system dynamic recording systems, power system time synchronization and measurement systems, smart grid instruments, integrated automation systems for 110kV and below voltage level substations, intelligent distribution network scheduling and integrated automation systems Energy internet system integration and intelligent equipment, as well as providing 110kV and below substations, distribution network maintenance, trial operation and maintenance services, as well as energy internet planning, design, consulting, and operation and maintenance services. One of the company's main products, the technology and market share of power fault recording devices, has always been in a leading position in the industry, and has been successfully applied to multiple national key projects such as the world's largest hydropower station - the Yangtze River Three Gorges Water Control Project, the 1000kV AC/± 800kV DC ultra-high voltage project, and nuclear power plants. In terms of medical and health business, the company focuses on life and health, and currently mainly engages in the research and development, production, sales, and service of medical informatization and clinical in vitro diagnostic related products. The medical informatization business focuses on the construction of smart medical community, smart hospital, AI+big data, and Internet plus+operation. It can provide products and services for medical institutions, health administrative departments, and personal health services. The main products of clinical in vitro diagnosis business are eleven categories of biochemical in vitro diagnostic reagents and medical testing equipment, which can provide comprehensive clinical in vitro diagnostic laboratory solutions for various medical units. The company uses medical informatization business as a platform resource, collaborates on the development of in vitro diagnostic reagents and medical laboratory equipment, implements the "data product service" strategy, and gradually builds an interactive and synergistic medical and health industry chain. It has now provided products and services to thousands of medical institutions and related units nationwide. In terms of industrial investment, the company optimizes resource allocation by building a scientific, efficient, and professional industrial investment platform, and conducts mergers and acquisitions and investments around the company's strategic layout and industrial development in the fields of smart grids and healthcare, to assist the company's development. The company adheres to the business philosophy of creating value for customers and innovation driven development, with integrity, responsibility, unity, and collaboration, providing customers with first-class technology, products, and services, achieving common development among customers, employees, and the company, and striving to become a respected and sustainable enterprise in society. |
| Headquarter | Wuhan |
| Establish Date | 11/16/2001 |
| Listed Code | 300018.SZ |
| Listed Date | 10/30/2009 |
| Chairman | Xu Junhong. |
| CEO | Lu Chunming. |
| Website | www.zyhd.com.cn |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
